Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from Extended CEA
2015
This article, published in PLOS ONE, conducts an extended cost-effectiveness analysis (ECEA) of two fully publicly financed interventions in Ethiopia: pneumococcal vaccination for newborns and pneumonia treatment for under-five children. The authors apply ECEA methods and estimate the program impact on: (1) government program costs; (2) pneumonia and pneumococcal deaths averted; (3) household expenses related to pneumonia/pneumococcal disease treatment averted; (4) prevention of household medical impoverishment; and (5) distributional consequences across the wealth strata of the population. The results indicate that vaccine and treatment interventions for children can bring large health and financial benefits to households in Ethiopia, most particularly among the poorest socio-economic groups.
Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from Extended CEA
Source:
Johansson KA, Memirie ST, Pecenka C, Jamison DT, Verguet S. Health Gains and Financial Protection from Pneumococcal Vaccination and Pneumonia Treatment in Ethiopia: Results from an Extended Cost-Effectiveness Analysis. PLOS One 2015; 10 (12). https://doi.org/10.1371/journal.pone.0142691